SAE1 and myositis disease: Few studies have reported the clinical utility of LIA in detecting anti-SAE1 autoantibody and its impact on different clinical subsets, including patients with IIM or other CTDs without myositis in Asian cohorts, considering the low prevalence of anti-SAE1 autoantibody among Asians.